Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
10/16/2002 | EP1248801A1 Human polynucleotides, polypeptides, and antibodies |
10/16/2002 | EP1248637A1 Pharmaceutical composition comprising pectin effective in inhibiting the male reproductive toxicity |
10/16/2002 | EP1248626A2 Pharmaceutical compositions containing steroidal structures and uses thereof |
10/16/2002 | EP1248619A1 Amorphous paroxetine compositon |
10/16/2002 | EP1248517A2 Clonal propagation of primate offspring by embryo splitting |
10/16/2002 | EP0641203B1 Pharmaceutical compositions of an imidazolyl-akenoic acid salt and their use as angiotensin ii antagonists |
10/16/2002 | CN1374966A 嘌呤衍生物 Purine derivatives |
10/16/2002 | CN1374962A 8-phenyl-6,9-dihydro-[1,2,4]triazolo[3,4-i] purin-5-one derivatives |
10/16/2002 | CN1374953A Aromatic nitrogenous six-membered ring compounds |
10/16/2002 | CN1374952A Benzimidazolone derivatives and their use as phosphodiesterase inhibibors |
10/16/2002 | CN1374861A Methods for modulating the human sexual response |
10/16/2002 | CN1374858A For mulations for parenteral use of estramustine phosphate with improved pharmacological properties |
10/16/2002 | CN1374857A Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
10/16/2002 | CN1374129A Kidney-invigorating, vital energy-benefiting and blood nourishing oral liquor and its compounding process |
10/16/2002 | CN1374101A Kidney benefiting belt |
10/16/2002 | CN1092518C Gelding liquor for female livestocks |
10/15/2002 | US6465660 Isoindoloindolone compounds |
10/15/2002 | US6465519 Uses of modafinil and its D/L enantiomers |
10/15/2002 | US6465507 Antitumor agents |
10/15/2002 | US6465497 Arylthiazolidinedione derivatives |
10/15/2002 | US6465491 6-phenylpyridyl-2-amine derivatives |
10/15/2002 | US6465485 Tetrahydroisoquinoline derivatives as modulators of dopamine D3 receptors |
10/15/2002 | US6465468 Hydroxamic and carboxylic acid derivatives |
10/15/2002 | US6465465 Phosphodiesterase inhibitors |
10/15/2002 | US6465450 Vanadium (IV) complexes containing catecholate ligand and having spermicidal activity |
10/15/2002 | US6465445 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
10/15/2002 | US6464998 Composition for the in vivo production of therapeutic products |
10/15/2002 | CA2253795C Substituted 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors |
10/15/2002 | CA2191837C Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof |
10/15/2002 | CA2066943C Heterocyclically substituted phenylacetic acid derivatives, processes for their preparation and their use in medicaments |
10/15/2002 | CA2038985C Haloethyl-substituted steroidal enzyme inhibitors |
10/10/2002 | WO2002079408A2 Short bioactive peptides and methods for their use |
10/10/2002 | WO2002079299A1 Agent for the prevention and treatment of sexually transmitted diseases-i |
10/10/2002 | WO2002079220A2 Aminosterol compounds, their use in the preparation of meiosis-regulating medicaments and method for their preparation |
10/10/2002 | WO2002079203A1 Imidazo-triazine derivatives as pde 5 inhibitors |
10/10/2002 | WO2002079188A1 Pyrrolidine sulfonamides |
10/10/2002 | WO2002079163A1 Aminopyridine derivatives as estrogen receptor modulators |
10/10/2002 | WO2002079155A1 Pyrrolidine sulfonamides |
10/10/2002 | WO2002079152A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
10/10/2002 | WO2002079146A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
10/10/2002 | WO2002079143A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
10/10/2002 | WO2002078724A1 Biologically active aqueous fraction of an extract obtained from a mangrove plant salvadora persica l. |
10/10/2002 | WO2002078691A1 Duloxetine for treatment of hot flashes |
10/10/2002 | WO2002078683A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
10/10/2002 | WO2002078682A2 Estrogen replacement therapy |
10/10/2002 | WO2002078643A2 Immunomodulation and effect on cell processes relating to serotonin family receptors |
10/10/2002 | WO2002078580A1 Condom with an erectogenic composition |
10/10/2002 | WO2002058636A3 Novel cannabimimetic ligands |
10/10/2002 | WO2002051390A3 Amphiphilic lipid nanoparticles for peptide and/or protein incorporation |
10/10/2002 | WO2002051386A3 Lipid microparticles by cryogenic micronization |
10/10/2002 | WO2002050067A3 Pharmaceutical heterocyclic compounds |
10/10/2002 | WO2002046178A3 Benzofuran and benzothiophene derivatives as selective cox-2 inhibitors |
10/10/2002 | WO2002004612A3 Drug metabolizing enzymes |
10/10/2002 | US20020147345 FSH mimetics for the treatment of infertility |
10/10/2002 | US20020147343 Cell antiproliferative agents; anticancer agents |
10/10/2002 | US20020147341 Kinase inhibitor; benign prostatic hyperplasia |
10/10/2002 | US20020147201 Glycyrrhizin complex |
10/10/2002 | US20020147199 Process for the treatment of erectile dysfunction and product therefor |
10/10/2002 | US20020147198 Substituted arylamine derivatives and methods of use |
10/10/2002 | US20020147138 Anticancer agents |
10/10/2002 | US20020146805 DNA encoding the human serine protease T |
10/10/2002 | US20020146416 Human trk receptors and neurotrophic factor inhibitors |
10/10/2002 | DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes |
10/10/2002 | DE10114775A1 2-Mercapto-4,5-diarylimidazolderivate und ihre Verwendung in der Pharmazie 2-mercapto-4,5-diarylimidazolderivate and their use in the pharmaceutical |
10/10/2002 | CA2443050A1 Immunomodulation and effect on cell processes relating to serotonin family receptors |
10/10/2002 | CA2442525A1 Cyclopropylindole derivatives as selective serotonin reuptake inhibitors |
10/10/2002 | CA2442410A1 Duloxetine for treatment of hot flashes |
10/10/2002 | CA2442329A1 Imidazo-triazine derivatives as pde 5 inhibitors |
10/10/2002 | CA2441970A1 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
10/10/2002 | CA2441562A1 Short bioactive peptides and methods for their use |
10/10/2002 | CA2441252A1 Estrogen replacement therapy |
10/10/2002 | CA2438272A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
10/10/2002 | CA2438210A1 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds |
10/10/2002 | CA2437113A1 N-phenpropylcyclopentyl-substituted glutaramide derivatives as nep inhibitors for fsad |
10/09/2002 | EP1246923A2 Dna modification proteins |
10/09/2002 | EP1246920A2 Prevention of affections associated with porcine circovirus-2 |
10/09/2002 | EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
10/09/2002 | EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
10/09/2002 | EP1246836A2 Peptides for treatment of erectile dysfunction |
10/09/2002 | EP1246828A1 Benzosulfones with calcium antagonist activity |
10/09/2002 | EP1246789A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors |
10/09/2002 | EP1246630A1 Compositions and methods for facilitating skin growth and managing skin conditions |
10/09/2002 | EP1246629A1 Methods of using electron active compounds for managing cancer |
10/09/2002 | EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
10/09/2002 | EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
10/09/2002 | EP0944613B1 Benzopyran derivatives |
10/09/2002 | EP0827505B1 Selected soluble esters of hydroxyl-containing indolocarbazoles |
10/09/2002 | EP0783310B1 Novel hormonal medicaments and use thereof for correcting oestrogen deficiencies |
10/09/2002 | EP0754189B1 Receptor modulating agents and methods relating thereto |
10/09/2002 | EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder |
10/09/2002 | CN1373808A Calpains and their use |
10/09/2002 | CN1373771A Vaccine |
10/09/2002 | CN1373675A Composition for IVF |
10/09/2002 | CN1373126A Crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide |
10/09/2002 | CN1372974A Exterior-applied gel contaiing lysozyme as primary component and its preparing process |
10/09/2002 | CN1372968A Chinese medicine for treating ureteral occlusion |
10/09/2002 | CN1372954A Conception promoting pill |
10/09/2002 | CN1372945A Magnetotherapeutic medicinal pad and its preparing process |
10/09/2002 | CN1372937A Exterior-applied medicine for gynopathy |
10/09/2002 | CN1372931A Application of N-acetyl-D-aminoglucose in preparing medicines to treat cervical erosion |